Evidence mapPaperPMID 40142822Full record

ArticleJournal of clinical medicine2025

Effect of Oral Microbiota Composition on Metabolic Dysfunction-Associated Steatotic Liver Disease in the General Population.

Satoshi Sato, Chikara Iino, Keisuke Furusawa, Kenta Yoshida, Daisuke Chinda, Kaori Sawada, Tatsuya Mikami, Shigeyuki Nakaji, Shinsaku Fukuda, Hirotake Sakuraba

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Satoshi SatoDepartment of Gastroenterology, Hematology, and Clinical Immunology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.ORCID 0000-0001-5569-7093
Chikara IinoDepartment of Gastroenterology, Hematology, and Clinical Immunology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.
Keisuke FurusawaDepartment of Gastroenterology, Hematology, and Clinical Immunology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.
Kenta YoshidaDepartment of Gastroenterology, Hematology, and Clinical Immunology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.ORCID 0000-0002-3897-5546
Daisuke ChindaDivision of Endoscopy, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.ORCID 0000-0003-1690-5923
Kaori SawadaDepartment of Preemptive Medicine, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.
Tatsuya MikamiDepartment of Preemptive Medicine, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.ORCID 0000-0002-6657-6446
Shigeyuki NakajiDepartment of Preemptive Medicine, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.ORCID 0000-0002-4190-5151
Shinsaku FukudaDepartment of Gastroenterology, Hematology, and Clinical Immunology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.
Hirotake SakurabaDepartment of Gastroenterology, Hematology, and Clinical Immunology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

general populationmetabolic dysfunction-associated steatotic liver diseaseoral microbiota

Identifiers

PMID40142822
PMCPMC11943242

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.